As of Sep 29
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 1.50. The median estimate represents a +594.44% increase from the last price of 0.72.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.